Hostname: page-component-76d6cb85b7-vdhp9 Total loading time: 0 Render date: 2026-07-17T06:29:59.468Z Has data issue: false hasContentIssue false

Long-term sustainability of improvements in antibiotic prescribing after implementation of a local guideline for the management of patients hospitalized with skin and soft tissue infection

Published online by Cambridge University Press:  16 September 2025

Kira E. Frappa*
Affiliation:
Department of Pharmacy, Children’s Hospital Colorado, Aurora, CO, USA
Katherine C. Shihadeh
Affiliation:
Department of Pharmacy, Denver Health Medical Center, Denver, CO, USA
Margaret M. Cooper
Affiliation:
Department of Pharmacy, Denver Health Medical Center, Denver, CO, USA
Paul D. Paratore
Affiliation:
Department of Pharmacy, Denver Health Medical Center, Denver, CO, USA
Timothy C. Jenkins
Affiliation:
Division of Infectious Diseases, Department of Medicine, Denver Health Medical Center, Denver, CO, USA Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA
*
Corresponding author: Kira E. Frappa; Email: kira.frappa@childrenscolorado.org

Abstract

A local guideline for the management of patients hospitalized with skin and soft tissue infections was implemented at an academic, safety-net hospital. Immediate reductions in use of broad-spectrum antibiotics and durations of therapy were sustained over the subsequent 12 years.

Information

Type
Concise Communication
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1. Demographic and clinical characteristics

Figure 1

Figure 1. Panel A: Proportion of patients exposed to an antibiotic with broad gram-negative activity during the study, by quarter. Panel B: Aggregate proportion of patients exposed to an antibiotic with broad gram-negative activity during each study period. Panel C: Median total duration of antibiotic therapy during the study, by quarter. Panel D: Median total duration of antibiotic therapy during each study period (horizontal lines) with interquartile range (boxes), standard error (whiskers), and outliers (dots).

Supplementary material: File

Frappa et al. supplementary material

Frappa et al. supplementary material
Download Frappa et al. supplementary material(File)
File 14.3 KB